SEC Form 4 · accession 0001209191-16-147291
Fulgent Genetics, Inc. · FLGT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Mulay
Director
Period of report
Oct 26, 2016
Accepted (ET)
Oct 28, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674930
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 26, 2016 | A | 8,000 | $0.00 | A | 8,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents an award of 8,000 restricted stock units ("RSUs") granted to Dr. Mulay in connection with his appointment as a director of the Issuer. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest over a period of four years, with 1/4th of the shares subject to the RSUs vesting 12 months after September 28, 2016, and 1/16th of the remaining shares subject to the RSUs vesting at the end of every three-month period over the 36 months thereafter, subject to Dr. Mulay's continued service for the Issuer on each vesting date.